Associations between antipsychotic use, substance use and relapse risks in patients with schizophrenia - real-world evidence from two national cohorts
Markku Lähteenvuo, Jurjen J. Luykx, Heidi Taipale, Ellenor Mittendorfer-Rutz, Antti Tanskanen, Albert Batalla, Jari Tiihonen
doi: https://doi.org/10.1101/2022.02.09.22270707
Markku Lähteenvuo
1Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Niuvankuja 65, 70240, Kuopio, Finland
MD, PhDJurjen J. Luykx
2Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
3Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University Medical Centre, Maastricht, The Netherlands
4Second opinion outpatient clinic, GGNet Mental Health, Warnsveld, The Netherlands
MD, PhDHeidi Taipale
1Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Niuvankuja 65, 70240, Kuopio, Finland
5Karolinska Institutet, Department of Clinical Neuroscience, Division of Insurance Medicine, Berzelius väg 3. 171 77 Stockholm, Sweden
6University of Eastern Finland, School of Pharmacy, Yliopistonranta 1, 70210, Kuopio, Finland
PhDEllenor Mittendorfer-Rutz
5Karolinska Institutet, Department of Clinical Neuroscience, Division of Insurance Medicine, Berzelius väg 3. 171 77 Stockholm, Sweden
PhDAntti Tanskanen
1Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Niuvankuja 65, 70240, Kuopio, Finland
5Karolinska Institutet, Department of Clinical Neuroscience, Division of Insurance Medicine, Berzelius väg 3. 171 77 Stockholm, Sweden
PhDAlbert Batalla
2Department of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
MD, PhDJari Tiihonen
1Department of Forensic Psychiatry, University of Eastern Finland, Niuvanniemi Hospital, Niuvankuja 65, 70240, Kuopio, Finland
5Karolinska Institutet, Department of Clinical Neuroscience, Division of Insurance Medicine, Berzelius väg 3. 171 77 Stockholm, Sweden
7Center for Psychiatry Research, Norra Stationsgatan 69, 11364 Stockholm, Sweden
MD, PhD
Posted February 09, 2022.
Associations between antipsychotic use, substance use and relapse risks in patients with schizophrenia - real-world evidence from two national cohorts
Markku Lähteenvuo, Jurjen J. Luykx, Heidi Taipale, Ellenor Mittendorfer-Rutz, Antti Tanskanen, Albert Batalla, Jari Tiihonen
medRxiv 2022.02.09.22270707; doi: https://doi.org/10.1101/2022.02.09.22270707
Associations between antipsychotic use, substance use and relapse risks in patients with schizophrenia - real-world evidence from two national cohorts
Markku Lähteenvuo, Jurjen J. Luykx, Heidi Taipale, Ellenor Mittendorfer-Rutz, Antti Tanskanen, Albert Batalla, Jari Tiihonen
medRxiv 2022.02.09.22270707; doi: https://doi.org/10.1101/2022.02.09.22270707
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2877)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12609)
- Forensic Medicine (10)
- Gastroenterology (811)
- Genetic and Genomic Medicine (4479)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2868)
- Health Policy (1058)
- Hematology (378)
- HIV/AIDS (908)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4240)
- Nursing (227)
- Nutrition (620)
- Oncology (2223)
- Ophthalmology (631)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (486)
- Public and Global Health (6826)
- Radiology and Imaging (1502)
- Respiratory Medicine (908)
- Rheumatology (430)
- Sports Medicine (374)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)